Aristocrat Group Corp. (ASCC)
OTC PINK OTC PINK Primary 
Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next?
Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from the prior quarterly rate.
3 Dividend Aristocrat Stocks To Buy for Reliable Income In 2026
Dividend aristocrats tend to be some of the most reliable stocks. These companies have raised dividends for at least 25 consecutive years, showing steady long-term growth and strong financial discipline.
Dividend Aristocrat Kimberly-Clark Is Spending More Than It Generates on Its Dividend
Kimberly-Clark Corp. (NASDAQ: KMB) is undergoing the largest transformation in its 150-year history while maintaining a dividend that has increased for 54 consecutive years.
T. Rowe Price: Goldman Sachs Partnership Helps This High-Yield Dividend Aristocrat
T. Rowe Price Group, Inc. is reiterated as a Strong Buy, supported by a pristine balance sheet, robust free cash flow, and a compelling >8% combined yield. TROW delivered record AUM of $1.78 trillion despite $56.9 billion net outflows in 2025, aided by strong market returns and product diversification. Strategic initiatives include ETF launches, global expansion, and a partnership with Goldman Sachs, signaling adaptability and a potential safety net.
J.M. Smucker: Buy This Dividend Aristocrat While It's On Sale
J.M. Smucker is a value and income play, trading at a forward P/E of 11.6 and yielding 4.2%. SJM faces margin pressures, but portfolio simplification and cost savings are expected to stabilize profitability. Growth drivers like Uncrustables and Café Bustelo, combined with a well-covered dividend, support a "Buy" rating for potential strong total returns.
McCormick: A Dividend Aristocrat Priced For Perfection
McCormick is a Dividend Aristocrat that trades above intrinsic value, with a Hold rating justified by premium valuation and macro pressures not properly reflected. MKC's dividend comes with an ~80% payout ratio, currently trading at one of their highest yields, but consumer weakness and tariffs weigh on performance. Despite strategic sourcing and productivity initiatives, MKC faces intensifying competition from private labels and relies heavily on global supply chains.
Kimberly-Clark: Buy This Dividend Aristocrat While The Market Overreacts
Kimberly-Clark offers compelling value, trading near 52-week lows, with a 5% dividend yield and a forward P/E of 13.5. The planned Kenvue merger, despite market skepticism, positions KMB as a global consumer health leader, with $32 billion in annual revenue and $1.9 billion in expected synergies. KMB maintains robust profitability, a 20.7% ROIC, an 'A' credit rating, and a well-covered dividend, with 53 consecutive years of growth.
The Dividend Aristocrat With 53% Margins Just Widened the Gap on the Frozen Dividend Competitor
Kraft Heinz (NASDAQ: KHC) and PepsiCo (NASDAQ: PEP) both beat Q3 2025 earnings, but the results highlight two packaged food giants on starkly different trajectories.
Jim Cramer Says” Buy, Buy, Buy” This Recession-Resistant Dividend Aristocrat Stock
Jim Cramer has built his reputation around energized analysis of growth stocks and whatever is trending at the moment, mostly because that's what his audience wants to know about the most.
This Dividend Aristocrat Turned $100k Into $4 Million in 25 Years
When you first think about a Dividend Aristocrat stock, it's likely not Canadian Natural Resources (NYSE:CNQ ).
The 5 Best S&P 500 Dividend Aristocrat Stocks to Buy Before 2026
Investors love S&P 500 dividend stocks, especially those with dependable, high yields, because they provide a substantial passive income stream and offer significant total return potential.
Time To Buy This Future Dividend Aristocrat: Microsoft
Microsoft stands as a premier technology investment, leveraging cloud computing, AI, and enterprise software for robust, long-term growth. MSFT delivered Q1 2026 revenue of $77.7B (+18% YoY) and non-GAAP EPS of $4.13 (+23% YoY), with a 39.6% net profit margin. The stock trades at a forward P/E of 28.1, modestly below its nine-year average, offering a potential 12% upside by end-2026.
